Henna Kekki - UTU Research Portal

Henna Kekki

- Doctoral Researcher,
Department of Life Technologies (Faculty of Technology)

hekekk@utu.fi

+358 29 450 4600

+358 50 575 6076

Kiinamyllynkatu 10

Turku

ORCID identifier: https://orcid.org/0009-0009-9488-7434

Publications

1 of 2

Improved diagnostic performance of a phage display antibody-assisted intact free PSA assay as used in the four kallikrein concept applied to the IMPROD/multi-IMPROD study (2025)
- Clinica Chimica Acta
Khan, Md. Ferdhos L.; Perez, Ileana M.; Kekki, Henna; Taimen, Pekka; Boström, Peter J.; Jambor, Ivan; Ettala, Otto; Pahikkala, Tapio; Pettersson, Kim
(A1 Refereed original research article in a scientific journal)
Lectin-nanoparticle concept for free PSA glycovariant providing superior cancer specificity (2024)
- Clinica Chimica Acta
Kekki, Henna; Montoya Perez, Ileana; Taimen, Pekka; Boström, Peter; Gidwani, Kamlesh; Pettersson, Kim
(A1 Refereed original research article in a scientific journal)
Detection of Prostate Cancer Using Biparametric Prostate MRI, Radiomics, and Kallikreins: A Retrospective Multicenter Study of Men With a Clinical Suspicion of Prostate Cancer (2022)
- Journal of Magnetic Resonance Imaging
Perez Ileana Montoya, Merisaari Harri, Jambor Ivan, Ettala Otto, Taimen Pekka, Knaapila Juha, Kekki Henna, Khan Ferdhos L, Syrjälä Elise, Steiner Aida, Syvänen Kari T, Verho Janne, Seppänen Marjo, Rannikko Antti, Riikonen Jarno, Mirtti Tuomas, Lamminen Tarja, Saunavaara Jani, Falagario Ugo, Martini Alberto, Pahikkala Tapio, Pettersson Kim, Boström Peter J, Aronen Hannu J
(A1 Refereed original research article in a scientific journal)
A prognostic model for colorectal cancer based on CEA and a 48-multiplex serum biomarker panel (2021)
- Scientific Reports
Björkman Kajsa, Jalkanen Sirpa, Salmi Marko, Mustonen Harri, Kaprio Tuomas, Kekki Henna, Pettersson Kim, Böckelman Camilla, Haglund Caj
(A1 Refereed original research article in a scientific journal)
CA125: A superior prognostic biomarker for colorectal cancer compared to CEA, CA19-9 or CA242 (2021)
- Tumor Biology
Björkman Kajsa, Mustonen Harri, Kaprio Tuomas, Kekki Henna, Pettersson Kim, Haglund Caj, Böckelman Camilla
(A1 Refereed original research article in a scientific journal)
Nanoparticle-aided glycovariant assays to bridge biomarker performance and ctDNA results (2020)
- Molecular Aspects of Medicine
Gidwani K, Kekki H, Terävä J, Soukka T, Sundfeldt K, Pettersson K
(A1 Refereed original research article in a scientific journal)
Europium Nanoparticle-Based Sialyl-Tn Monoclonal Antibody Discriminates Epithelial Ovarian Cancer-Associated CA125 from Benign Sources (2019)
- The Journal of Applied Laboratory Medicine
Gidwani K, Nadeem N, Huhtinen K, Kekki H, Heinosalo T, Hynninen J, Perheentupa A, Poutanen M, Carpen O, Pettersson K, Lamminmäki U
(A1 Refereed original research article in a scientific journal)
A cancer-specific detection of serum CA125 improves differential diagnosis of epithelial ovarian cancer from benign conditions. (2018)
- Clinical Cancer Research
Huhtinen K, Gidwani K, Kekki H, Hynninen J, Salminen L, Perheentupa A, Poutanen M, Auranen A, Grenman S, Lamminmaki U, Carpen O, Pettersson K
(Other publication)
Improved cancer specificity in PSA assay using Aleuria aurantia lectin coated Eu-nanoparticles for detection (2017)
- Clinical Biochemistry
Henna Kekki, Mari Peltola, Sandra van Vliet, Chris Bangma, Yvette van Kooyk, Kim Pettersson
(A1 Refereed original research article in a scientific journal)
Uusi lektiini-avusteinen määrityskonsepti parantamaan CA-125-kasvainmerkkiaineen munasarjasyöpäspesifisyyttä (2017)
- Kliin lab
Kekki H, Gidwani K, Huhtinen K, Hynninen J, Pettersson K
(D1 Article in a professional journal)